The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells
10.1038/35021086
Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Coopman, P. J. P., Do, M. T. H., Barth, M., Bowden, E. T., Hayes, A. J., Basyuk, E., Blancato, J. K., Vezza, P. R., McLeskey, S. W., Mangeat, P. H., & Mueller, S. C. (2000). The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature, 406(6797), 742–747.

Authors 11
  1. Peter J. P. Coopman (first)
  2. Michael T. H. Do (additional)
  3. Mara Barth (additional)
  4. Emma T. Bowden (additional)
  5. Andrew J. Hayes (additional)
  6. Eugenia Basyuk (additional)
  7. Jan K. Blancato (additional)
  8. Phyllis R. Vezza (additional)
  9. Sandra W. McLeskey (additional)
  10. Paul H. Mangeat (additional)
  11. Susette C. Mueller (additional)
References 29 Referenced 250
  1. Cheng, A. M. & Chan, A. C. Protein tyrosine kinases in thymocyte development. Curr. Opin. Immunol. 9, 528 –533 (1997). (10.1016/S0952-7915(97)80106-9) / Curr. Opin. Immunol. by AM Cheng (1997)
  2. Kurosaki, T. Molecular mechanisms in B cell antigen receptor signaling. Curr. Opin. Immunol. 9, 309–318 (1997). (10.1016/S0952-7915(97)80075-1) / Curr. Opin. Immunol. by T Kurosaki (1997)
  3. Chu, D. H., Morita, C. T. & Weiss, A. The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol. Rev. 165, 167–180 (1998). (10.1111/j.1600-065X.1998.tb01238.x) / Immunol. Rev. by DH Chu (1998)
  4. Indik, Z. K., Park, J. G., Pan, X. Q. & Schreiber, A. D. Induction of phagocytosis by a protein tyrosine kinase. Blood 85, 1175–1180 (1995). (10.1182/blood.V85.5.1175.bloodjournal8551175) / Blood by ZK Indik (1995)
  5. Fluck, M., Zurcher, G., Andres, A. C. & Ziemiecki, A. Molecular characterization of the murine Syk protein tyrosine kinase cDNA, transcripts and protein. Biochem. Biophys. Res. Commun. 213, 273–281 (1995). (10.1006/bbrc.1995.2126) / Biochem. Biophys. Res. Commun. by M Fluck (1995)
  6. Coopman, P. J., Do, M. T. H., Thompson, E. W. & Mueller, S. C. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin. Canc. Res. 4, 507–515 (1998). / Clin. Canc. Res. by PJ Coopman (1998)
  7. Coopman, P. J., Thomas, D. M., Gehlsen, K. R. & Mueller, S. C. Integrin α3β1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells. Mol. Biol. Cell 7, 1789–1804 ( 1996). (10.1091/mbc.7.11.1789) / Mol. Biol. Cell by PJ Coopman (1996)
  8. Thompson, E. W. et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell Physiol. 150, 534– 544 (1992). (10.1002/jcp.1041500314) / J. Cell Physiol. by EW Thompson (1992)
  9. Law, C. L. et al. Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex. J. Biol. Chem. 269, 12310–12319 (1994). (10.1016/S0021-9258(17)32717-5) / J. Biol. Chem. by CL Law (1994)
  10. Nagai, K., Inazu, T. & Yamamura, H. p72syk is activated by vanadate plus H2O 2 in porcine platelets and phosphorylates GTPase activating protein on tyrosine residue(s). J. Biochem. (Tokyo) 116, 1176–1181 (1994). (10.1093/oxfordjournals.jbchem.a124646) / J. Biochem. (Tokyo) by K Nagai (1994)
  11. Fargnoli, J. et al. Syk mutation in Jurkat E6-derived clones results in lack of p72syk expression. J. Biol. Chem. 270, 26533–26537 (1995). (10.1074/jbc.270.44.26533) / J. Biol. Chem. by J Fargnoli (1995)
  12. Brunner, N. et al. lacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis. Eur. J. Cancer 28A, 1989–1995 (1992). (10.1016/0959-8049(92)90245-W) / Eur. J. Cancer by N Brunner (1992)
  13. Kurebayashi, J. et al. Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. Cancer Res. 53, 2178– 2187 (1993). / Cancer Res. by J Kurebayashi (1993)
  14. Takata, M. et al. Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. EMBO J. 13, 1341–1349 ( 1994). (10.1002/j.1460-2075.1994.tb06387.x) / EMBO J. by M Takata (1994)
  15. Peters, J. D., Furlong, M. T., Asai, D. J., Harrison, M. L. & Geahlen, R. L. Syk, activated by cross-linking the B-cell antigen receptor, localizes to the cytosol where it interacts with and phosphorylates alpha-tubulin on tyrosine. J. Biol. Chem. 271, 4755–4762 (1996). (10.1074/jbc.271.9.4755) / J. Biol. Chem. by JD Peters (1996)
  16. Lingle, W. L. & Salisbury, J. L. Altered centrosome structure is associated with abnormal mitoses in human breast tumors. Am. J. Pathol. 155, 1941–1951 (1999). (10.1016/S0002-9440(10)65513-7) / Am. J. Pathol. by WL Lingle (1999)
  17. Miranti, C. K., Leng, L., Maschberger, P., Brugge, J. S. & Shattil, S. J. Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1. Curr. Biol. 8, 1289– 1299 (1998). (10.1016/S0960-9822(07)00559-3) / Curr. Biol. by CK Miranti (1998)
  18. Williams, S. et al. Reconstitution of T cell antigen receptor-induced Erk2 kinase activation in Lck-negative JCaM1 cells by Syk. Eur. J. Biochem. 245, 84–90 ( 1997). (10.1111/j.1432-1033.1997.00084.x) / Eur. J. Biochem. by S Williams (1997)
  19. Deckert, M., Tartare-Deckert, S., Couture, C., Mustelin, T. & Altman, A. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 5, 591–604 ( 1996). (10.1016/S1074-7613(00)80273-3) / Immunity by M Deckert (1996)
  20. Law, C. L., Chandran, K. A., Sidorenko, S. P. & Clark, E. A. Phospholipase C-gamma1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol. Cell. Biol. 16, 1305–1315 ( 1996). (10.1128/MCB.16.4.1305) / Mol. Cell. Biol. by CL Law (1996)
  21. Minobe, K. et al. Allelic loss on chromosome 9q is associated with lymph node metastasis of primary breast cancer. Jpn. J. Cancer Res. 89, 916–922 (1998). (10.1111/j.1349-7006.1998.tb00649.x) / Jpn. J. Cancer Res. by K Minobe (1998)
  22. Turner, M. et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378, 298–302 (1995). (10.1038/378298a0) / Nature by M Turner (1995)
  23. Cheng, A. M. et al. Syk tyrosine kinase required for mouse viability and B-cell development. Nature 378, 303– 306 (1995). (10.1038/378303a0) / Nature by AM Cheng (1995)
  24. Murphy, M. A. et al. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl- deficient mice. Mol. Cell Biol. 18, 4872–4882 (1998). (10.1128/MCB.18.8.4872) / Mol. Cell Biol. by MA Murphy (1998)
  25. Schaeren-Wiemers, N. & Gerfin-Moser, A. A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry 100, 431– 440 (1993). (10.1007/BF00267823) / Histochemistry by N Schaeren-Wiemers (1993)
  26. Emmert-Buck, M. R. et al. Laser capture microdissection. Science 274, 998–1001 (1996). (10.1126/science.274.5289.998) / Science by MR Emmert-Buck (1996)
  27. Yagi, S., Suzuki, K., Hasegawa, A., Okumura, K. & Ra, C. Cloning of the cDNA for the deleted Syk kinase homologous to Zap- 70 from human basophilic leukemia cell line (KU812). Biochem. Biophys. Res. Commun. 200, 28–34 (1994). (10.1006/bbrc.1994.1409) / Biochem. Biophys. Res. Commun. by S Yagi (1994)
  28. Pinkel, D. et al. Cytogenetic analysis by in situ hybridization with fluorescently labeled nucleic acid probes. Cold Spring Harbor Symp. Quant. Biol. 51, 151–157 ( 1986). (10.1101/SQB.1986.051.01.018) / Cold Spring Harbor Symp. Quant. Biol. by D Pinkel (1986)
  29. Fang, W., Hartmann, N., Chow, D. T., Riegel, A. T. & Wellstein, A. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. J. Biol. Chem. 267, 25889–25897 (1992). (10.1016/S0021-9258(18)35692-8) / J. Biol. Chem. by W Fang (1992)
Dates
Type When
Created 23 years ago (July 26, 2002, 4:45 a.m.)
Deposited 2 years, 11 months ago (Sept. 19, 2022, 5:12 a.m.)
Indexed 1 month, 2 weeks ago (July 1, 2025, 7:29 a.m.)
Issued 25 years ago (Aug. 17, 2000)
Published 25 years ago (Aug. 17, 2000)
Published Online 25 years ago (Aug. 17, 2000)
Published Print 25 years ago (Aug. 17, 2000)
Funders 0

None

@article{Coopman_2000, title={The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells}, volume={406}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/35021086}, DOI={10.1038/35021086}, number={6797}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Coopman, Peter J. P. and Do, Michael T. H. and Barth, Mara and Bowden, Emma T. and Hayes, Andrew J. and Basyuk, Eugenia and Blancato, Jan K. and Vezza, Phyllis R. and McLeskey, Sandra W. and Mangeat, Paul H. and Mueller, Susette C.}, year={2000}, month=aug, pages={742–747} }